(Q41940828)

English

Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202

scientific article published on 8 August 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202 (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

adaptive radiation therapy

0 references

author name string

Mingxin Che

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Michelle DeSilvio

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Alan Pollack

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

David J Grignon

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Varagur Mohan Venkatesan

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Gerald E Hanks

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Howard M Sandler

7

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

RTOG

8

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

language of work or name

0 references

publication date

8 August 2007

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

69

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

1117-1123

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

p53 is mutated in a subset of advanced-stage prostate cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

5 June 2018

Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

14 June 2018

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

18 August 2018

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

18 August 2018

p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

18 August 2018

Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

18 August 2018

Association of p53 mutations with metastatic prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770594

18 August 2018

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17689883

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2007.04.070

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

release_zqfzd6s2ufdivpppijavt7hmxa

1 reference

https://api.fatcat.wiki/v0/release/zqfzd6s2ufdivpppijavt7hmxa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41940828&oldid=1836096388"